How can the answer be improved?Tell us how. May 16, · In this study, it was confirmed that Ki is as a prognostic factor in breast cancer patients in a routine setting. A published review article concluded increasing evidence that Ki is a valuable prognostic marker but as to its predictive role its applicability is limited .Cited by:
Ki (or Ki67) is used as a measure of the proliferative activity of breast cancer cells. Ki is an antigen, a substance that causes the immune system to produce antibodies against it. It is a protein found only in growing, dividing cells (and not in cells in the resting phase of the cell growth cycle). Sep 19, · Ki Ki is a protein in cells that increases as they prepare to divide into new cells. A staining process can measure the percentage of tumor cells that are positive for Ki The more positive cells there are, the more quickly they are dividing and forming new cells.
Oct 01, · Most of us Triple negatives have high KI scores. That just means that it is a fast growing tumor with rapidly dividing cells. Fortunately, that is exactly what chemo works best on, but unfortunately, that is exactly what CHEMO works best on. Chemo is your best bet. Background. Currently the choice of breast cancer therapy is based on prognostic factors. The proliferation marker Ki is used increasingly to determine the method of therapy. The current study analyses the predictive value of Ki in foreseeing breast cancer patients’ responses to neoadjuvant chemotherapy. Methods. This study includes patients with invasive breast cancer treated between Cited by: 9.
MIB1 is the antibody most often used to label the Ki antigen. The more cells MIB1 attaches to in a tissue sample, the more likely the tumor cells are to grow and divide rapidly. The result of this test is reported as the percentage of Kipositive cells (the proportion of cancer cells .